F552 in District of Columbia. Pick another state for the same tag.
Against expectation — 2023
District of Columbia cites F552 more often than its own record predicts
Versus expected share1.52×
1.52 times the share F552 takes of citations nationally.
Share of District of Columbia citations0.45%
Of every deficiency written in District of Columbia in 2023, this is the portion that was F552.
District of Columbia0.45%
National0.30%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What District of Columbia surveyors wrote
F552 findings written in District of Columbia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMarch 10, 2023
Based on record review, family interview, and staff interview, for one (1) of 105 sampled residents, the facility's staff failed to notify a resident's family regarding use of medications (Depakote and Exelon). (Resident #74.)
The findings included:
Resident #74 was admitted to the facility with multiple diagnoses including Paranoid Schizophrenia, Anxiety and Dementia with other Behavioral Disturbances.
Review of Resident #74's medical record revealed the following:
A physician's order dated 11/29/22 directed, Depakote Delayed Released 50 MG (milligrams) - give 1 tablet via g-tube (gastrostomy tube) two times a day for mood disorder. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction